Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Live, attenuated viruses have been the most successful vaccines in monkey models of human immunodeficiency virus type 1 (HIV-1) infection. However, there are several safety concerns about using such an anti-HIV vaccine in humans, including reversion of the vaccine strain to virulence and recombination with endogenous retroviral sequences to produce new infectious and potentially pathogenic viruses. Because testing in humans would inevitably carry a substantial risk, we set out to test the genetic stability of multiply deleted HIV constructs in perpetuated tissue culture infections. The Δ3 candidate vaccine strain of HIV-1 contains deletions in the viral long terminal repeat (LTR) promoter and the vpr and nef genes. This virus replicates with delayed kinetics, but a profound enhancement of virus replication was observed after approximately 2 months of culturing. Analysis of the revertant viral genome indicated that the three introduced deletions were maintained but a 39-nucleotide sequence was inserted in the LTR promoter region. This insert was formed by duplication of the region encoding three binding sites for the Sp1 transcription factor. The duplicated Sp1 region was demonstrated to increase the LTR promoter activity, and a concomitant increase in the virus replication rate was measured. In fact, duplication of the Sp1 sites increased the fitness of the Δ3 virus (Vpr/Nef/U3) to levels higher than that of the singly deleted ΔVpr virus. These results indicate that deleted HIV-1 vaccine strains can evolve into fast-replicating variants by multiplication of remaining sequence motifs, and their safety is therefore not guaranteed. This insight may guide future efforts to develop more stable anti-HIV vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL
Domingo, E., & Holland, J. J. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.151 · Cited by 1,514 · cited 1×
“This may not come as a surprise, because there is ample evidence that HIV-1, which replicates as a quasispecies, is capable of overcoming a variety of selective pressures that are intended to limit its replication, including potent antiviral drugs (18).”
BackgroundDas, A. T., Klaver, B., & Berkhout, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3090-3097.1995 · Cited by 149
Self-citation
Research works printed but not linked: 58
- 10.1128/jvi.59.2.284-291.1986 · DOI · Paper page
- 10.1016/S0140-6736(95)92540-6 · DOI · Paper page
- 10.1126/science.7892606 · DOI · Paper page
- 10.1002/j.1460-2075.1996.tb00777.x · DOI · Paper page
- 10.1093/nar/25.5.940 · DOI · Paper page
- 10.1128/jvi.70.10.6723-6732.1996 · DOI · Paper page
- 10.1038/nm1097-1055 · doi:10.1038/nm1097-1055
- 10.1128/jvi.67.2.743-752.1993 · DOI
- 10.1128/jvi.71.7.5495-5504.1997 · DOI
- 10.1126/science.277.5329.1035 · doi:10.1126/science.277.5329.1035
- 10.1128/jvi.71.2.1089-1096.1997 · doi:10.1128/jvi.71.2.1089-1096.1997
- 10.1126/science.1470917 · DOI · Paper page
- 10.1128/jvi.71.3.2346-2356.1997 · DOI · Paper page
- 10.1006/viro.1998.9124 · DOI
- 10.1126/science.270.5238.988 · DOI · Paper page
- 10.1089/aid.1992.8.411 · DOI
- 10.1016/0092-8674(89)90393-0 · DOI · Paper page
- 10.1128/jvi.69.4.2378-2383.1995 · DOI · Paper page
- 10.1089/aid.1994.10.343 · DOI
- 10.1038/nm0198-065 · DOI · Paper page
- 10.1128/jvi.65.9.4691-4698.1991 · DOI
- 10.1128/mcb.9.8.3269-3283.1989 · doi:10.1128/mcb.9.8.3269-3283.1989
- 10.1128/jvi.69.8.4906-4913.1995 · DOI
- 10.1128/JVI.72.5.3773-3778.1998 · DOI
- 10.1016/0092-8674(86)90332-6 · DOI · Paper page
- 10.1128/jvi.69.8.4807-4813.1995 · DOI · Paper page
- 10.1128/jvi.70.5.3118-3126.1996 · doi:10.1128/jvi.70.5.3118-3126.1996
- 10.1128/jvi.67.10.6224-6233.1993 · DOI · Paper page
- 10.1126/science.3008338 · DOI · Paper page
- 10.1002/j.1460-2075.1994.tb06555.x · DOI
- 10.1128/jvi.68.6.3830-3840.1994 · DOI · Paper page
- 10.1016/0042-6822(92)90274-S · DOI
- 10.1128/JVI.72.8.6629-6636.1998 · DOI
- 10.1128/jvi.68.11.7021-7029.1994 · DOI · Paper page
- 10.1128/jvi.71.11.8657-8665.1997 · DOI
- 10.1038/nm0197-17 · doi:10.1038/nm0197-17
- 10.1006/viro.1997.8847 · doi:10.1006/viro.1997.8847
- 10.1128/jvi.65.3.1414-1419.1991 · DOI
- 10.1016/0092-8674(95)90304-6 · DOI
- 10.1128/jvi.65.9.4786-4797.1991 · DOI · Paper page
- 10.1128/jvi.65.8.4350-4358.1991 · DOI · Paper page
- 10.1089/aid.1997.13.1611 · DOI
- 10.1101/gad.4.4.659 · DOI
- 10.1128/jvi.71.11.8141-8148.1997 · DOI
- 10.1073/pnas.93.15.7955 · DOI
- 10.1099/0022-1317-77-12-2969 · DOI
- 10.1128/jvi.69.10.6572-6576.1995 · DOI
- 10.1128/jvi.70.12.8277-8284.1996 · DOI
- 10.1073/pnas.90.10.4419 · DOI
- 10.1016/0092-8674(95)90306-2 · DOI · Paper page
- Tsichlis P. N. Lazo P. A. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses Retroviral insertion and oncogene activation. Kung H. J. Vogt P. K. 1991 95 171 Springer-Verlag KG Berlin Germany · DOI
- 10.1126/science.270.5239.1218 · DOI
- 10.1006/viro.1997.8786 · DOI
- 10.1128/jvi.69.8.5117-5123.1995 · DOI · Paper page
- 10.1128/jvi.63.9.3595-3600.1989 · DOI
- 10.1128/jvi.70.6.3724-3733.1996 · DOI · Paper page
- 10.1038/nm0197-32 · DOI
- 10.1128/JVI.72.4.3300-3306.1998 · doi:10.1128/jvi.72.4.3300-3306.1998
Cited by
Tet-On Systems For Doxycycline-inducible Gene Expression
T. Das, A., Tenenbaum, L., & Berkhout, B. (2016) · Current Gene Therapy · doi:10.2174/1566523216666160524144041 · Cited by 434
Self-citationJeeninga, R. E., Hoogenkamp, M., Armand-Ugon, M., de Baar, M., Verhoef, K., & Berkhout, B. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3740-3751.2000 · Cited by 290
Self-citationOrtinski, P. I., O’Donovan, B., Dong, X., & Kantor, B. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.04.002 · Cited by 146
Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat
Verhoef, K., Marzio, G., Hillen, W., Bujard, H., & Berkhout, B. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.979-987.2001 · Cited by 88
“Testifying to the genetic instability of such strains is the recent demonstration that the HIV-1 D3 vaccine candidate, which contains three deletions in nonessential parts of the genome, is able to regain full replication capacity within 4 months of replication in tissue culture (11).”
BackgroundSelf-citationMarzio, G., Verhoef, K., Vink, M., & Berkhout, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111031498 · Cited by 81
Self-citation
Metadata
- Authors
- Berkhout, B., Verhoef, K., van Wamel, J. L. B., & Back, N. K. T.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 1999-02
- Volume
- 73
- Issue
- 2
- Pages
- 1138-1145
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W1938941047
- Cited by
- 84
- References
- 2
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains. https://app.cochat.ai/papers/10.1128/jvi.73.2.1138-1145.1999
- The paper
- Berkhout, B., Verhoef, K., van Wamel, J. L. B., & Back, N. K. T. (1999). Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains. Journal of Virology. https://doi.org/10.1128/jvi.73.2.1138-1145.1999
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.